Bruker Corporation

NASDAQ:BRKR

Medical - Devices

Healthcare
$63.26 -1.92%

-$1.07 today

Market cap
$9.66B
Beta
1.30
P/E (TTM)
-718.1
EPS (TTM)
-$0.08
Dividend yield
0.37%
52W Low $28.53High $64.54

Volume 1.73M

Average 2.41M

BRKR Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Bruker CorporationNASDAQ: BRKR

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 49.6%

Gross margin was 49.6% in Q2 FY2026, up 4.7 pp from a year earlier. On a trailing-twelve-month basis it was 46.7%, down 1.6 pp year over year. Over 3 fiscal years it narrowed by 5.7 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
49.6%+2.3 pp QoQ
Last fiscal yearDec 2025
45.9%-3.1 pp YoY
LTMJun 2026
46.7%-1.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.7 pp——
1 year-3.1 pp——
3 years-5.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
45.9%
Year-over-year change
-3.1pp

Gross Margin vs competitors

How BRKR compares with its peers on the latest reported figures

  • BRKR's LTM Jun 2026 gross margin of 46.7% is the 9th highest of the 11 companies compared; the peer median is 52.9%.
  • Its year-over-year change of -1.6 pp is the 8th highest of 11, against a peer median of -0.6 pp.
  • Over three fiscal years its change of -5.7 pp compares with a peer median of -1.7 pp.
BRKR Competitors Peer median
Gross Margin for BRKR and competitors
Company Period LTM level YoY 3-year change
TECHBio-Techne CorporationLTM Sep 202665.8% +0.4 pp-2.0 pp
QGENQiagen N.V.LTM Jun 202661.8% -1.1 pp-2.9 pp
DHRDanaher CorporationLTM Sep 202658.6% -2.7 pp+0.2 pp
MTDMettler-Toledo International Inc.LTM Jun 202658.4% -0.2 pp+2.2 pp
AAgilent Technologies, Inc.LTM Jul 202653.7% +0.8 pp-1.9 pp
RVTYRevvity, Inc.LTM Jul 202652.1% -1.9 pp-0.1 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202651.9% -0.9 pp-3.9 pp
WATWaters CorporationLTM Jul 202650.8% -8.2 pp-0.2 pp
BRKRBruker CorporationLTM Jun 202646.7% -1.6 pp-5.7 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202641.4% +1.0 pp-1.4 pp
PACBPacific Biosciences of California, Inc.LTM Mar 202637.1% +20.9 pp-6.5 pp
Peer median (excluding BRKR) 52.9%-0.6 pp-1.7 pp

Competitors are the stored peer set for BRKR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.42B2.53B2.96B3.37B3.44B
Cost of Revenue1.21B1.23B1.45B1.72B1.86B
Gross Profit1.21B1.31B1.51B1.65B1.58B
Gross Margin50.0%51.6%51.0%49.0%45.9%
Research & Development220.8M235.9M294.8M376.5M395.2M
Selling, General & Admin562.3M607.4M729.4M893.8M946.5M
Operating Expenses796.3M873M1.08B1.4B1.34B
Depreciation & Amortization89.1M88.7M114.9M183.8M220.3M
EBITDA497M518.7M675.5M438.6M302.6M
EBITDA Margin20.6%20.5%22.8%13.0%8.8%
Operating Income413.3M432.7M436.9M253.1M236M
Operating Margin17.1%17.1%14.7%7.5%6.9%
Interest Income900K2.8M7.5M9.3M14.8M
Interest Expense14.3M16.1M16.4M47.9M60.3M
Other Income / Expenses(19.7M)(17.8M)109.3M(47.9M)(215M)
Income Before Tax393.6M414.9M546.2M205.2M21M
Pre-Tax Margin16.3%16.4%18.4%6.1%0.6%
Income Tax Expense113M116.4M117.7M91.4M29.3M
Net Income277.1M296.6M427.2M113.1M(8.6M)
Net Margin11.5%11.7%14.4%3.4%-0.3%
EPS (Basic)1.832.002.920.76(0.15)
EPS (Diluted)1.811.992.900.76(0.15)
Weighted Avg Shares151.4M148.6M146.4M149M151.8M
Weighted Avg Shares (Diluted)152.9M149.4M147.2M149.5M151.8M

Bruker Corporation

NASDAQ:BRKR

Intrinsic Alpha fair value

Locked

Current Price

$63.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.